1. Home
  2. EMN vs DVA Comparison

EMN vs DVA Comparison

Compare EMN & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMN
  • DVA
  • Stock Information
  • Founded
  • EMN 1920
  • DVA 1994
  • Country
  • EMN United States
  • DVA United States
  • Employees
  • EMN N/A
  • DVA N/A
  • Industry
  • EMN Major Chemicals
  • DVA Misc Health and Biotechnology Services
  • Sector
  • EMN Industrials
  • DVA Health Care
  • Exchange
  • EMN Nasdaq
  • DVA Nasdaq
  • Market Cap
  • EMN 9.2B
  • DVA 10.9B
  • IPO Year
  • EMN 1993
  • DVA 1995
  • Fundamental
  • Price
  • EMN $78.33
  • DVA $136.18
  • Analyst Decision
  • EMN Buy
  • DVA Hold
  • Analyst Count
  • EMN 13
  • DVA 4
  • Target Price
  • EMN $99.46
  • DVA $157.00
  • AVG Volume (30 Days)
  • EMN 1.8M
  • DVA 828.5K
  • Earning Date
  • EMN 07-24-2025
  • DVA 05-12-2025
  • Dividend Yield
  • EMN 4.24%
  • DVA N/A
  • EPS Growth
  • EMN 1.14
  • DVA 14.90
  • EPS
  • EMN 7.86
  • DVA 10.11
  • Revenue
  • EMN $9,362,000,000.00
  • DVA $12,968,524,000.00
  • Revenue This Year
  • EMN N/A
  • DVA $6.00
  • Revenue Next Year
  • EMN $3.35
  • DVA $3.66
  • P/E Ratio
  • EMN $9.98
  • DVA $13.48
  • Revenue Growth
  • EMN 2.79
  • DVA 5.11
  • 52 Week Low
  • EMN $70.90
  • DVA $131.76
  • 52 Week High
  • EMN $114.50
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • EMN 43.74
  • DVA 37.73
  • Support Level
  • EMN $79.54
  • DVA $136.50
  • Resistance Level
  • EMN $82.83
  • DVA $140.42
  • Average True Range (ATR)
  • EMN 1.86
  • DVA 3.66
  • MACD
  • EMN 0.05
  • DVA -0.59
  • Stochastic Oscillator
  • EMN 10.14
  • DVA 11.71

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: